February 2015 Product Spotlight: Emerging Technologies
Featured emerging technologies include a digital pathology image capture platform, an infectious disease testing platform, and an acute kidney injury test.
Read MorePosted by Jenny Lower | Feb 2, 2015 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits |
Featured emerging technologies include a digital pathology image capture platform, an infectious disease testing platform, and an acute kidney injury test.
Read MorePosted by Steve Halasey | Jan 15, 2015 | Cancer, Leukemia, Melanoma, Molecular Diagnostics, Research, Unknown Origin & Other Cancer Types |
After its ASH 2014 debut, the RainDance HemOnc Consortium, an international panel of clinical research experts, will focus on developing assays for liquid biopsy research of myeloid disorders.
Read MorePosted by Jenny Lower | Jan 8, 2015 | Compliance |
The Centers for Disease Control’s guidelines for testing high-risk specimens include using centrifuges with sealed rotors and a Class II biosafety cabinet.
Read MorePosted by Steve Halasey | Jan 6, 2015 | Cancer, Molecular Diagnostics, Pancreatic |
With reimbursement coverage from Blue Shield of California and acceptance as a Medicare provider, Invitae looks to bring genetic testing into mainstream medicine.
Read MorePosted by Jenny Lower | Dec 30, 2014 | Allergy & Autoimmune, Coagulation Testing, Hematology & Serology |
Akers Biosciences has entered into multiyear distribution agreements with Cryopep SARL and DiaLine AG for its PIFA Heparin and PF4 rapid assay products, which determine whether a patient being treated with the blood thinner heparin may be developing a drug allergy.
Read More